Visualization and a smaller package

Article

The new 23G endoscope proves it's flexibility: A case study

Ocular inflammation is a ubiquitous symptom that could have any number of causes, and improved visualization within the eye is often imperative to correct diagnosis. I was recently referred a patient diagnosed with pseudoexfoliation syndrome and had undergone cataract surgery five years previously. The patient had undergone multiple vitrectomy surgeries for the chronic inflammation, and a wide-angle viewing system and scleral depression at the time of the earlier vitrectomies did not reveal an aetiology. Intraocular lymphoma was suspected and the patient was referred to me to undergo an endoscopic vitrectomy.

This case could be compared to severe endophthalmitis where the anterior segment view is compromised. Without an endoscope the physician would have to remove infected material almost blindly, resulting in the debulking of relatively little of the toxic infectious and/or inflammatory debris. While these are eyes with low visual potential, using the endoscope enables the physician to achieve a far greater removal of the damaging material, and increases the likelihood of saving the eye and preserving at least some vision.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.